For: | Qin SY, Jiang HX, Lu DH, Zhou Y. Association of interleukin-10 polymorphisms with risk of irritable bowel syndrome: A meta-analysis. World J Gastroenterol 2013; 19(48): 9472-9480 [PMID: 24409078 DOI: 10.3748/wjg.v19.i48.9472] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i48/9472.htm |
Number | Citing Articles |
1 |
M.J. Schmulson, M. Saps, M. Bashashati. Abnormal immune regulation in children with irritable bowel syndrome. Revista de Gastroenterología de México (English Edition) 2015; 80(1): 3 doi: 10.1016/j.rgmxen.2015.02.004
|
2 |
Shiwei Zhu, Ben Wang, Qiong Jia, Liping Duan. Candidate single nucleotide polymorphisms of irritable bowel syndrome: a systemic review and meta-analysis. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1084-z
|
3 |
Ryo Katsumata, Akiko Shiotani. Irritable Bowel Syndrome. 2024; : 67 doi: 10.1007/978-981-97-8410-3_7
|
4 |
Maria Gazouli, Mira M. Wouters, Lejla Kapur-Pojskić, May-Bente Bengtson, Eitan Friedman, Gordana Nikčević, Christiana A. Demetriou, Agata Mulak, Javier Santos, Beate Niesler. Lessons learned — resolving the enigma of genetic factors in IBS. Nature Reviews Gastroenterology & Hepatology 2016; 13(2): 77 doi: 10.1038/nrgastro.2015.206
|
5 |
Lienda Bashier El, Doa Shams, Nazik Babikr, Mohammed Madani, Sara Abdelghani, Hisham Ali Waggia. Serum Levels of Interferon Gamma INF-γ and Interleukin 10 Il-10: an Immunological Aspect among Irritable Bowel Syndrome Patients. Pakistan Journal of Biological Sciences 2020; 23(7): 898 doi: 10.3923/pjbs.2020.898.903
|
6 |
Shi-Wei Zhu, Zuo-Jing Liu, Qing-Hua Sun, Li-Ping Duan. Effect of the interleukin 10 polymorphisms on interleukin 10 production and visceral hypersensitivity in Chinese patients with diarrhea-predominant irritable bowel syndrome. Chinese Medical Journal 2019; 132(13): 1524 doi: 10.1097/CM9.0000000000000306
|
7 |
Zhenwu Lin, Zhong Wang, John P Hegarty, Tony R Lin, Yunhua Wang, Sue Deiling, Rongling Wu, Neal J Thomas, Joanna Floros. Genetic association and epistatic interaction of the interleukin-10 signaling pathway in pediatric inflammatory bowel disease. World Journal of Gastroenterology 2017; 23(27): 4897-4909 doi: 10.3748/wjg.v23.i27.4897
|
8 |
Rajan Singh, Uday C. Ghoshal, Sushil Kumar, Balraj Mittal. Genetic variants of immune-related genes IL17F and IL10 are associated with functional dyspepsia: A case–control study. Indian Journal of Gastroenterology 2017; 36(5): 343 doi: 10.1007/s12664-017-0788-7
|
9 |
E. A. Trush, A. E. Karchevskaya, R. V. Maslennikov, E. A. Poluektova, O. S. Shifrin, V. T. Ivashkin. Single Nucleotide Polymorphisms, Associated with Increased Risk of Irritable Bowel Syndrome with Predominant Constipation: A Meta Analysis. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2024; 34(3): 62 doi: 10.22416/1382-4376-2024-34-3-62-77
|
10 |
Jasbir Makker, Sridhar Chilimuri, Jonathan N Bella. Genetic epidemiology of irritable bowel syndrome. World Journal of Gastroenterology 2015; 21(40): 11353-11361 doi: 10.3748/wjg.v21.i40.11353
|
11 |
Jing E, Shun-Yao Liu, Dan-Na Ma, Guo-Qing Zhang, Shi-Lu Cao, Bo Li, Xiao-hua Lu, Hong-Yan Luo, Li Bao, Xiao-Mei Lan, Rong-Guo Fu, Ya-Li Zheng. Nanopore-based full-length transcriptome sequencing for understanding the underlying molecular mechanisms of rapid and slow progression of diabetes nephropathy. BMC Medical Genomics 2024; 17(1) doi: 10.1186/s12920-024-02006-2
|
12 |
Sunil Kumar, Ratnakar Shukla, Prabhat Ranjan, Awanish Kumar. Interleukin-10: A Compelling Therapeutic Target in Patients With Irritable Bowel Syndrome. Clinical Therapeutics 2017; 39(3): 632 doi: 10.1016/j.clinthera.2017.01.030
|
13 |
D. S. Stashkevich, S. V. Belyaeva, Yu. Yu. Filippova, A. L. Burmistrova. INTERGENIC INTERACTIONS OF CYTOKINE GENES IL1, IL1RA, IL6, IL10 AND TNFА IN PATIENTS WITH IRRITABLE BOWEL SYNDROME AND ULCERATIVE COLITIS IN RUSSIAN POPULATION OF THE CHELYABINSK REGION. Medical Immunology (Russia) 2018; 20(6): 921 doi: 10.15789/1563-0625-2018-6-921-926
|
14 |
Qi-Yun Xiao, Xiu-Cai Fang, Xiao-Qing Li, Gui-Jun Fei. Ethnic differences in genetic polymorphism associated with irritable bowel syndrome. World Journal of Gastroenterology 2020; 26(17): 2049-2063 doi: 10.3748/wjg.v26.i17.2049
|
15 |
Hai-Xia Ren, Fa-Can Zhang, He-Sheng Luo, Guo Zhang, Lie-Xin Liang. Role of mast cell-miR-490-5p in irritable bowel syndrome. World Journal of Gastroenterology 2017; 23(1): 93-102 doi: 10.3748/wjg.v23.i1.93
|
16 |
Rong Yang, Chong Zhang, Armah Malik, Zhi-Da Shen, Jian Hu, Yi-He Wu. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: A meta-analysis based on case-control studies. World Journal of Gastroenterology 2014; 20(44): 16765-16773 doi: 10.3748/wjg.v20.i44.16765
|
17 |
Mengjiao Ren, Jian Ma, Minye Qu. Network pharmacology integrated with molecular docking and molecular dynamics simulations to explore the mechanism of Shaoyao Gancao Tang in the treatment of asthma and irritable bowel syndrome. Medicine 2024; 103(50): e40929 doi: 10.1097/MD.0000000000040929
|
18 |
M. Schmulson, M. Saps, M. Bashashati. Regulación inmune anormal en niños con síndrome de intestino irritable. Revista de Gastroenterología de México 2015; 80(1): 3 doi: 10.1016/j.rgmx.2015.01.001
|